Figure 3.
Figure 3. Inhibition of specific [Ca++]i oscillations in platelets interacting with immobilized VWF. A blood cell suspension, prepared as described in the legend to Figure 2, was perfused over immobilized VWF at the shear rate of 3000 s–1 for 90 seconds. Surface interacting platelets were identified, and their [Ca++]i was monitored in real time for the next 30 seconds during translocation or stationary adhesion. Typical α/β and γ Ca++ peaks are identified in the control platelets. The same peaks were also seen after treatment with ASA (400 μM) or the anti-P2Y12 inhibitor (AR-C69931MX, 1 μM). In contrast, after addition of the P2Y1 inhibitor (MRS2216, 12.5 μM), no type γ [Ca++]i oscillations occurred, whereas α/β peaks were apparently unchanged. Comparable results were obtained in 4 different experiments.

Inhibition of specific [Ca++]ioscillations in platelets interacting with immobilized VWF. A blood cell suspension, prepared as described in the legend to Figure 2, was perfused over immobilized VWF at the shear rate of 3000 s–1 for 90 seconds. Surface interacting platelets were identified, and their [Ca++]i was monitored in real time for the next 30 seconds during translocation or stationary adhesion. Typical α/β and γ Ca++ peaks are identified in the control platelets. The same peaks were also seen after treatment with ASA (400 μM) or the anti-P2Y12 inhibitor (AR-C69931MX, 1 μM). In contrast, after addition of the P2Y1 inhibitor (MRS2216, 12.5 μM), no type γ [Ca++]i oscillations occurred, whereas α/β peaks were apparently unchanged. Comparable results were obtained in 4 different experiments.

Close Modal

or Create an Account

Close Modal
Close Modal